Israel Englander Cara Therapeutics, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 587,909 shares of CARA stock, worth $152,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares

587,909

Previous 586,755 0.2%

Holding current value

$152,856

Previous $152,000 19.74%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.26 - $0.38 $300 - $438	1,154 Added 0.2%	587,909 $182,000
Q2 2024 Aug 14, 2024	SELL	$0.24 - $0.92 $18,018 - $69,072	-75,079 Reduced 11.34%	586,755 $152,000
Q1 2024 May 15, 2024	BUY	$0.52 - $1.05 $101,216 - $204,379	194,647 Added 41.66%	661,834 $602,000
Q4 2023 Feb 14, 2024	SELL	$0.6 - $1.65 $166,590 - $458,122	-277,650 Reduced 37.28%	467,187 $345,000
Q2 2023 Aug 14, 2023	BUY	$2.83 - $4.94 $2.07 Million - $3.62 Million	732,330 Added 5855.36%	744,837 $2.11 Million
Q1 2023 May 15, 2023	SELL	$4.89 - $12.27 $28,410 - $71,288	-5,810 Reduced 31.72%	12,507 $61,000
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $162,654 - $233,908	18,317 New	18,317 $197,000
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $5.8 Million - $10.8 Million	778,186 New	778,186 $7.11 Million
Q4 2021 Feb 14, 2022	SELL	$11.99 - $18.14 $432,371 - $654,146	-36,061 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.55 - $16.06 $416,504 - $579,139	36,061 New	36,061 $557,000
Q2 2021 Aug 16, 2021	SELL	$12.38 - $29.19 $621,575 - $1.47 Million	-50,208 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$15.07 - $21.71 $1.78 Million - $2.56 Million	-118,105 Reduced 70.17%	50,208 $1.09 Million
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $1.96 Million - $2.5 Million	154,480 Added 1116.75%	168,313 $2.55 Million
Q3 2020 Nov 16, 2020	SELL	$12.34 - $17.92 $1.14 Million - $1.65 Million	-92,321 Reduced 86.97%	13,833 $176,000
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $1.32 Million - $1.84 Million	106,154 New	106,154 $1.82 Million
Q1 2020 May 14, 2020	SELL	$9.12 - $17.78 $362,009 - $705,759	-39,694 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $639,470 - $1.03 Million	39,694 New	39,694 $639,000
Q3 2019 Nov 14, 2019	SELL	$18.28 - $26.91 $1.03 Million - $1.52 Million	-56,607 Closed	0 $0
Q2 2019 Aug 15, 2019	SELL	$17.68 - $21.57 $19.4 Million - $23.7 Million	-1,097,779 Reduced 95.1%	56,607 $1.22 Million
Q2 2019 Aug 14, 2019	BUY	$17.68 - $21.57 $20 Million - $24.4 Million	1,128,889 Added 4427.54%	1,154,386 $55.3 Million
Q1 2019 May 14, 2019	SELL	$14.41 - $19.64 $4.16 Million - $5.67 Million	-288,848 Reduced 91.89%	25,497 $500,000
Q4 2018 Feb 14, 2019	SELL	$12.45 - $23.47 $92,316 - $174,030	-7,415 Reduced 2.3%	314,345 $4.09 Million
Q3 2018 Nov 14, 2018	BUY	$17.57 - $23.95 $4.64 Million - $6.32 Million	263,863 Added 455.75%	321,760 $7.71 Million
Q2 2018 Aug 14, 2018	BUY	$11.6 - $19.27 $671,605 - $1.12 Million	57,897 New	57,897 $1.11 Million
Q1 2018 May 15, 2018	SELL	$11.77 - $16.08 $1.32 Million - $1.8 Million	-112,222 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$11.86 - $14.08 $1.1 Million - $1.31 Million	92,841 Added 479.03%	112,222 $1.37 Million
Q3 2017 Nov 14, 2017	BUY	$12.6 - $16.34 $244,200 - $316,685	19,381	19,381 $265,000

Others Institutions Holding CARA

# of Institutions

Shares Held

12.8M

Call Options Held

Put Options Held

View Full List

About Cara Therapeutics, Inc.

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

More about CARA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account